CGC
What one share of Canopy Growth holds
Medicinal Chemicals and Botanical Products
We believe in the power of a plant – not as a trend or commodity, but as a catalyst for elevating human potential. For the patient seeking to function more fully in their everyday lives, the veteran finding relief, and the individual rediscovering balance, clarity, and purpose.
Canopy Growth’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.60 |
|---|---|
| Profit | −$0.47 |
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | −$0.17 |
| Cash and investments | $0.56 |
| Debt | $0.40 |
| Book value | $1.15 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2018 | $3.43 | −$2.96 | $7.74 | −$11.32 | — | $43.63 |
| 2019 | $6.47 | −$21.03 | $18.41 | −$33.70 | — | $150.37 |
| 2020 | $8.61 | −$28.54 | $15.22 | −$31.91 | — | $93.53 |
| 2021 | $11.13 | −$35.54 | $3.35 | −$12.84 | — | $72.32 |
| 2022 | $9.70 | −$6.32 | $0.75 | −$11.88 | — | $71.27 |
| 2023 | $5.44 | −$53.49 | $0.15 | −$9.25 | — | $10.84 |
| 2024 | $2.95 | −$6.88 | $0.03 | −$2.83 | — | $3.25 |
| 2025 | $1.80 | −$3.40 | $0.07 | −$1.18 | — | $1.81 |
| 2026 | $0.69 | −$0.64 | $0.01 | −$0.17 | — | $1.18 |